Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Ampersand 2018 Limited Partnership Create: Alert

All | News | Filings
Date FiledTypeDescription
11/12/2021 SC 13D/A Ampersand 2018 Limited Partnership reports a 38.9% stake in INTERPACE BIOSCIENCES, INC.
05/18/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/19/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/17/2020 4 Ampersand 2018 Limited Partnership (10% Owner) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.
Txns: Disposed/sold 270 convertible preferred @ $0
Granted 27,000 convertible preferred @ $0
Granted 1,000 convertible preferred @ $1000, valued at $1M
01/17/2020 SC 13D/A Ampersand 2018 Limited Partnership reports a 39.4% stake in INTERPACE BIOSCIENCES, INC.
10/18/2019 4 Ampersand 2018 Limited Partnership (10% Owner) has filed a Form 4 on Interpace Diagnostics Group, Inc.
Txns: Granted 130 convertible preferred @ $100000, valued at $13M
10/15/2019 4 Ampersand 2018 Limited Partnership (10% Owner) has filed a Form 4 on Interpace Diagnostics Group, Inc.
Txns: Granted 80 convertible preferred @ $0
Disposed/sold 80 convertible preferred @ $0
07/25/2019 SC 13D Ampersand 2018 Limited Partnership reports a 19.6% stake in INTERPACE DIAGNOSTICS GROUP, INC.
07/25/2019 3 Ampersand 2018 Limited Partnership (10% Owner) has filed a Form 3 on Interpace Diagnostics Group, Inc.
03/15/2018 D Form D - Notice of Exempt Offering of Securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy